ランキング価格はじめての方へ
  1. 米国企業
  2. Organogenesis Holdings Inc.
  3. Raw

Organogenesis Holdings Inc.ORGO

時価総額
$6.7億
PER
再生医療製品の大手。Apligraf、Dermagraft、PuraPlyなどの皮膚代替製品を展開。2024年11月12日のシリーズA優先株で1.3億ドルを調達、7,921,731株の株式買戻し。米国中心に研究生産拠点を保有し、2024年12月31日時点で従業員約869人。
概要財務
サマリーテーブルに戻る
2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日		2024年
12月31日
Net income---65-4018951651
Depreciation and amortization--------14
Amortization of intangible assets--4645553
Reduction in the carrying value of right-of-use assets-----6788
Non-cash interest expense--3000000
Deferred interest expense---121100
Deferred tax expense (benefit)--000-3222-11
Loss on disposal of property and equipment---1-0-0-1-4-0-1
Loss on lease termination--------1-
Loss on extinguishment of term loan---2-2--2---0
Provision for Other Credit Losses-------14
Adjustment for excess and obsolete inventories-----3-12-10-7-8
Stock-based compensation--11247911
Impairment charge--------19
Write Down Of Capitalized Internal-Use Software Costs--------4
Accounts receivable--7519299-632
Inventories--51179986
Prepaid expenses and other current and other assets--11100103
Operating leases-------814
Accounts payable---05-143-0-2
Accrued expenses and other current liabilities--0319-1239
Other liabilities--0-1-0-600-1
Net cash provided by operating activities--586,604-61-34762253114
Purchases of property and equipment--262131342410
Net cash used in investing activities-310,000,000--2-6-25-31-34-24-10
Term loan repayments under the 2021 Credit Agreement-----13567
Proceeds from Issuance of Convertible Preferred Stock--------121
Payments for the repurchase of common stock--------25
Principal repayments of finance lease obligations---123001
Proceeds from Stock Options Exercised--00322-1
Payments of withholding taxes in connection with RSUs vesting-----1101
Payments of deferred acquisition consideration----401--
Net cash provided by (used in) financing activities--327,578827942-1-2-628
Change in cash, cash equivalents and restricted cash--19392430-11132
Cash paid for interest-----6355
Income Taxes Paid--0001137
Cumulative Effect Adjustment For Adoption-------1-
Deferred Acquisition Consideration And Earnout Liability For Business Acquisition----5-1--
Change in purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities---------0
Right-of-use assets obtained through operating lease obligations-----54165
Right-of-use assets obtained through finance lease obligations-------3-
Redeemable convertible preferred stock issuance costs included in accrued expenses--------0
Prepaid rent reclassified to right-of-use assets--------0
Accretion to redemption value and cumulative dividends on redeemable convertible preferred stock--------2